In the bone microenvironment, TGF-β is released from bone during bone resorption and it stimulates breast cancer cells to produce osteolytic factors, such as interleukin 11 (IL-11), that mediate osteolysis by stimulating osteoclast formation and bone resorption activity [8]–[10]. This evidence concerns the gene IL11 and breast carcinoma.